Skip to main content
TipRanks
Go Ultimate75% OFF

David Domzalski Insider Profile

25 Followers

David Domzalski, President & CEO, Director at Yarrow Bioscience, holds 347.17K shares in Yarrow Bioscience (Ticker: YARW), holds 319.32K shares in Foamix Pharma (Ticker: FOMX).

David Domzalski's Trading History

YARW
Yarrow Bioscience
Jul 24, 2026President & CEO, DirectorUninformative Sell70.66K$4.84M
FOMX
Foamix Pharma
Feb 24, 2020―Uninformative Buy―$954.78K

You May Also Like

David Domzalski insider profile FAQ

What is the percentage of profitable transactions made by David Domzalski?
The percentage of profitable transactions made by David Domzalski is 92%.
What is the average return per transaction made by David Domzalski?
The average return per transaction made by David Domzalski is 25.20%.
What stocks does David Domzalski hold?
David Domzalski holds: YARW, FOMX stocks.
What was David Domzalski’s latest transaction?
David Domzalski’s latest transaction was an Uninformative Sell of $70.66K.
What was David Domzalski's most profitable transaction?
David Domzalski’s most profitable transaction was an Informative Sell of FOMX stock on July 3, 2018. The return on the trade was 54.20%.
What is David Domzalski's role in Yarrow Bioscience?
David Domzalski's role in Yarrow Bioscience is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.